Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN

Delayed Quote. Delayed  - 05/25 09:59:59 pm
149.61 USD   +2.00%
05/19 ALEXION PHARMAC : Researchers to Present Late-Breaking Data on ALXN1..
05/04 ALEXION PHARMAC : to Present at the Bank of America Merrill Lynch 20..
04/28 Sanofi launches $9.3 billion fight for U.S. cancer firm Medivatio..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/19/2016 05/20/2016 05/23/2016 05/24/2016 05/25/2016 Date
139.03(c) 142.52(c) 142.51(c) 146.67(c) 149.61 Last
1 304 226 975 544 981 838 1 169 477 1 395 921 Volume
-2.32% +2.51% -0.01% +2.92% +2.00% Change
More quotes
Financials ($)
Sales 2016 3 059 M
EBIT 2016 1 330 M
Net income 2016 687 M
Debt 2016 1 591 M
Yield 2016 -
Sales 2017 3 761 M
EBIT 2017 1 742 M
Net income 2017 1 097 M
Debt 2017 516 M
Yield 2017 -
P/E ratio 2016 48,18
P/E ratio 2017 30,35
EV / Sales 2016 11,3x
EV / Sales 2017 8,87x
Capitalization 32 857 M
More Financials
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, engages in the innovation, development, and commercialization of life-transforming therapeutic products for treating patients with severe and ultra-rare disorders.It focuses on developing products for the treatment of diseases in the... 
Sector
Pharmaceuticals
Calendar
07/21Earnings Release
More about the company
Surperformance© ratings of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on ALEXION PHARMACEUTICALS, I
05/19 ALEXION PHARMACEUTICALS : Researchers to Present Late-Breaking Data on ALXN1210 ..
05/16 ALEXION PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holder..
05/04 ALEXION PHARMACEUTICALS : to Present at the Bank of America Merrill Lynch 2016 H..
04/28 ALEXION PHARMACEUTICALS INC : Results of Operations and Financial Condition, Fin..
04/28 Sanofi launches $9.3 billion fight for U.S. cancer firm Medivation
04/28DJALEXION PHARMACEUTICALS : Profit Declines but Revenue Rises
04/28DJALEXION PHARMACEUTICALS : Profit Declines but Revenue Rises
04/28 ALEXION PHARMACEUTICALS : misses Street 1Q forecasts
More news
Sector news : Biopharmaceuticals
10:56p Computer Sciences and Sanofi rise; Express and Alibaba fall
10:41p Sanofi moves to oust Medivation board in $9.3 billion takeover fight
10:35p Sanofi moves to oust Medivation board in $9.3 billion takeover fight
More sector news : Biopharmaceuticals
News from SeekingAlpha
09:30a Achillion's Pipeline Strengthens, With Near-Term Potential Catalysts
06:38a Delta Air Lines Is A Buy - Cramer's Lightning Round (5/24/16)
05/19 Latest Indication For Soliris And U.S. Regulators Decide On ZS-9
05/18 PIERIS PHARMACEUTICALS : The Blockbuster In Antibody Mimetics
05/16 ELEVEN BIOTHERAPEUTICS : A Buyout Likely Coming


Comments 
Advertisement
Chart ALEXION PHARMACEUTICALS, I
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Full-screen chart
Technical analysis trends ALEXION PHARMACEU...
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions